MetCancer

MetCancer — Viewing Cancer as a Metabolic Disease

MetCancer is an educational and scientific platform that presents a paradigm shift: cancer is not primarily a genetic disease but a metabolic one. Rather than viewing tumors strictly through the lens of mutated genes, MetCancer emphasizes how disruptions in cellular energy production — especially mitochondrial function — underlie many cancers.

Core Focus & Philosophy

  • Mitochondrial dysfunction as root cause
    The MetCancer framework highlights that damage or decline in mitochondrial respiration forces cells to rely on less efficient, fermentative energy pathways. This metabolic shift creates the environment for abnormal growth and cancer development. Learn more at MetCancer Literature.
  • Beyond genetics
    While genetic mutations are common in cancers, MetCancer argues they are often downstream effects of metabolic collapse, not the initiating cause. The platform suggests treating the metabolic dysfunction itself may offer powerful therapeutic avenues.
  • Research & resources
    MetCancer hosts a library of studies and writings that support the metabolic theory of cancer. These include historical works and modern publications demonstrating how cellular metabolism, redox states, and mitochondrial health intersect with tumor growth. Visit MetCancer Literature for in-depth materials.

Why It Matters

New lens for treatment strategies
If cancer is metabolic, therapies that target cellular energy pathways, mitochondrial repair, oxidative stress, and metabolic flexibility may open alternatives to purely genetic or toxic treatments.

Growing scientific support
The concept that cancer involves metabolic reprogramming is increasingly supported in peer-reviewed literature. For example, Dr. Thomas N. Seyfried’s work “Cancer as a Metabolic Disease” describes how energy metabolism disruption is a hallmark of cancer. (Read the publication)

Personal empowerment & exploration
MetCancer encourages individuals to learn, question, and explore how lifestyle, diet, and metabolic interventions might support mitochondrial health and reduce cancer risk or progression.


For more information and research, visit the official MetCancer website.